Saint Maur des Fossés, France

Serge Adnot


 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Serge Adnot: Pioneering Advances in Pulmonary Hypertension Treatment

Introduction: Serge Adnot, an inventor based in Saint Maur des Fossés, France, has made significant contributions to the field of pharmaceuticals with his innovative ideas and inventions. With one patent to his name, he has focused on advancing treatments for pulmonary hypertension. His work is essential in improving patient outcomes and demonstrates the importance of innovation in medicine.

Latest Patents: Serge Adnot holds a patent for the use of Roflumilast, Roflumilast N-Oxide, or a pharmaceutically acceptable salt of either for the treatment of pulmonary hypertension. This invention also includes the use of Roflumilast, Roflumilast N-oxide, or their salts in combination with a PDE5 inhibitor for more effective treatment options. This patent represents a significant advancement in therapeutic approaches to managing pulmonary conditions.

Career Highlights: Adnot's career is highlighted by his association with Takeda GmbH, a leading global pharmaceutical company known for its commitment to research and development. His role in this company allows him to work at the forefront of medicinal science, contributing to the development of important therapeutic agents.

Collaborations: Throughout his work, Serge Adnot has collaborated with esteemed colleagues, including Rolf Beume and Armin Hatzelmann. These partnerships signify the importance of teamwork and shared knowledge in the invention process, leading to advancements in patient therapies and innovations in the industry.

Conclusion: Serge Adnot exemplifies the role of innovators in addressing critical health challenges through his patent for Roflumilast and his contributions at Takeda GmbH. His work continues to influence the treatment landscape for pulmonary hypertension, highlighting the importance of innovative thinking in the pharmaceutical industry. The collaborations and dedication displayed by Adnot and his coworkers are vital for the future of medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…